Study reveals the limited effects of antibiotics on various diseases like cough, maintaining research to guide proper management of endotracheal infections.

Transparency, patient education, and regulatory oversight are essential for improving the FDA's accelerated drug approval program, especially for cancer drugs.

Relyvrio's promise in ALS treatment highlights the importance of patient advocacy for deadly diseases.